ლე ლაბორატუა სერვიეს წარმომომადგენლობა

PharmaDistribution

ID 202211338 · FY 2018–2024 · 7 years

ფილიალის ძირითად საქმიანობას წარმოადგენს სს „ლე ლაბორატუა სერვიე“-ს დამხმარე საქმიანობის განხორციელება (კომპანიის პროდუქციის შესახებ ინფორმირება და მხარდამჭერი საქმიანობა).

curated 2026-07-27

Compare with peers Screen Pharma Annual report FY2024

Key metrics

FY2024

Revenue & margins

Bars are revenue on the left axis; lines are EBITDA and net margin on the right.

latest FY 2024: ₾10.9m

Financial statements

consolidated · GEL

FY–financial ratiosXLSX

Ratio	2018	2019	2020	2021	2022	2023	2024
Margins
Gross Margin	97.9%	99.0%	100.0%	100.0%	100.0%	100.0%	100.0%
EBITDA Margin	0.2%	-57.4%	-12.1%	18.6%	10.1%	-26.2%	19.5%
EBITDAR	273	-1,851	-340	2,144	1,194	-1,260	2,509
EBITDAR Margin	4.6%	-49.6%	-6.2%	23.3%	15.7%	-20.2%	23.1%
EBIT Margin	-2.4%	-61.9%	-16.3%	15.9%	6.2%	-30.2%	16.9%
Net Profit Margin	0.9%	-59.3%	-6.2%	17.7%	-1.7%	-29.3%	16.5%
Operating Expense % of Sales	97.8%	156.4%	112.1%	81.4%	89.9%	126.2%	80.5%
Returns
Return on Assets (ROA)	1.4%	-124.4%	-18.6%	44.2%	-3.6%	-95.8%	49.5%
Return on Equity (ROE)	1.4%	-124.6%	-23.8%	53.1%	-4.5%	-166.6%	62.1%
ROIC [EBIT / Invested Capital]	-16.0%	-379.3%	-94.9%	440.4%	97.7%	-273.1%	386.3%
Leverage & liquidity
Debt-to-Assets	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Debt-to-Equity	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Debt-to-EBITDA	0.00x	N/A	N/A	0.00x	0.00x	N/A	0.00x
Equity-to-Assets	99.7%	99.8%	78.2%	83.2%	78.8%	57.5%	79.7%
Net Debt	-3,105	-1,167	-493	-2,726	-2,439	-408	-2,418
Cash & Equivalents	3,105	1,167	493	2,726	2,439	408	2,418
Total Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Efficiency & working capital
Inventory Turnover	N/A	0.69x	N/A	N/A	N/A	N/A	N/A
Days Inventory Outstanding (DIO)	N/A	528.3	N/A	N/A	N/A	N/A	N/A
Receivables Turnover	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Days Sales Outstanding (DSO)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Payables Turnover	12.30x	12.67x	N/A	N/A	N/A	N/A	N/A
Days Payable Outstanding (DPO)	29.7	28.8	N/A	N/A	N/A	N/A	N/A
Cash Conversion Cycle	-29.7 days	499.5 days	N/A	N/A	N/A	N/A	N/A
Asset Turnover	1.48x	2.10x	2.98x	2.50x	2.05x	3.27x	2.99x
Cash flow & dividends
Operating Cash Flow	319	-1,976	-300	2,428	973	-1,639	2,119
Free Cash Flow (OCF − Capex proxy)	27	-2,006	-982	2,330	345	-2,047	2,051
Cash Conversion (OCF / EBITDA)	3190.0%	N/A	N/A	142.0%	126.0%	N/A	99.9%
Dividends Declared	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend Payout Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.

Ownership & group structure

Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.

companyinfo.ge · fetched 2026-07-15